The Bryden Wood podcast
Founded 30 years ago, Bryden Wood champions a radical transformation in design and construction. Our global team delivers comprehensive services across architecture, engineering, and digital delivery, driving innovation from concept to completion.
We've led projects like the UK's first net-zero commercial building and Europe's highest IT yield data centre, showcasing our commitment to sustainability and efficiency. Our approach harnesses digital tools and manufacturing processes for smarter, faster solutions.
Emphasising systematic, standardised, and configurable solutions, we align with the rapid evolution of technology in energy, healthcare, and infrastructure. Our 'Design to Value' ethos seeks not only cost and time efficiency but societal benefit.
On The Bryden Wood podcast, we share insights, innovations, and thought leadership from industry experts and our own groundbreaking projects. Whether you're a professional in the built environment or simply passionate about the future of design, this podcast offers thought-provoking discussions and actionable ideas.
Tune in to explore how we're modernising critical infrastructure and shaping a better, more sustainable world.
The Bryden Wood podcast
AI-Enabled Cancer Care: PharosAI | Bryden Wood Podcast
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Developing a cancer drug is one of the most expensive, slow, and failure-prone processes in modern science. PharosAI is trying to change that – by building multimodal, AI-ready datasets from donated cancer tissue samples and making them available to researchers, biotech companies, and clinicians.
In this episode, Technical Director Adrian La Porta speaks with PharosAI's Dr Lucie Burgess (COO) and Dr Emma Colliver (Research Fellow) about what it takes to curate cancer data at scale, why federated learning matters for patient privacy, where AI is already transforming diagnostics, and what synthetic patients could mean for clinical trials.
Whether you work in life sciences, pharma manufacturing, digital health, or clinical data governance, understanding how AI is reshaping the drug discovery pipeline has direct implications for how and when new facilities will need to be built. This one is worth your time.
Topics covered:
00:00 Introduction
00:01 What is PharosAI?
00:06 Why AI can fundamentally change cancer care
00:08 The venture behind the mission
00:12 Lowering the barrier for UK biotech
00:16 Are we at an inflection point?
00:20 AI in diagnostics – what's already working
00:24 Misconceptions about AI in biotech
00:30 Data – acquiring, cleaning, and structuring
00:34 Patient privacy, consent, and NHS data
00:37 What cancer care could look like in 10 years
00:40 Why this work matters personally
To learn more about Bryden Wood's Design to Value philosophy, visit www.brydenwood.com. You can also follow Bryden Wood on LinkedIn.
